UC neurosurgery department awarded exclusive grant
June 2, 2021
The Neurosurgery Research and Education Foundation awarded UC's Department of Neurosurgery with a prestigious grant.
June 2, 2021
The Neurosurgery Research and Education Foundation awarded UC's Department of Neurosurgery with a prestigious grant.
May 4, 2021
The North American Skull Base Society awards Norberto Andaluz, MD, for innovation and research.
March 17, 2021
Charles Prestigiacomo, MD, created the Advanced Anatomy of the Head and Neck elective, offered to fourth-year students at the UC College of Medicine who are getting ready to match in surgical residencies and begin performing procedures on patients. He and colleagues are seeing how this class is better preparing students to begin their careers with a little more “real-life” practice.
August 27, 2018
Since taking the role as chair of the Department of Neurosurgery at the University of Cincinnati (UC) College of Medicine on July 1, 2017, Joseph Cheng, MD, has been working to grow his academic and clinical team to meet patients’ needs. Over the last year, the college has hired sixeight neurosurgery faculty with expertise in the areas of brain tumor, cerebrovascular, spinal and functional neurosurgery, rounding out Cheng’s specialty in all aspects of spinal surgery, including treatment for degenerative disease, deformities, trauma, tumors spinal cord injury and complex revision spinal surgeries.
September 8, 2020
Five African-American researchers and healthcare professionals on UC’s medical campus have received sizable grants from the National Institutes of Health during the past 18 months. The faculty members were interviewed by WCPO to help showcase innovation and the diverse voices and perspectives they bring as the healthcare community attempts to ease health disparities in communities of color in Cincinnati and beyond.
August 17, 2020
Mario Zuccarello, MD, has been appointed director of the Brain Tumor Center at the University of Cincinnati (UC) Gardner Neuroscience Institute and the UC Cancer Center.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.